Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Cash Flow Reinvestment Rate
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Cash Flow Reinvestment Rate of 0.93x as of September 2025, reinvesting CN¥82.19 Million (capex CN¥82.19 Million ) from operating cash flow of CN¥88.00 Million. See 002317 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Guangdong Zhongsheng Pharmaceutical Co L (002317) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Guangdong Zhongsheng Pharmaceutical Co Ltd. See 002317 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.49x | CN¥841.02 Million | CN¥337.84 Million | CN¥228.26 Million | ▼ -57.1% |
| 2023 | 5.80x | CN¥1.11 Billion | CN¥190.61 Million | CN¥363.06 Million | ▼ -33.1% |
| 2022 | 8.67x | CN¥547.02 Million | CN¥63.07 Million | CN¥267.96 Million | ▲ +681.6% |
| 2021 | 1.11x | CN¥691.07 Million | CN¥622.77 Million | CN¥213.76 Million | ▼ -47.2% |
| 2020 | 2.10x | CN¥291.87 Million | CN¥138.93 Million | CN¥154.43 Million | ▲ +100.4% |
| 2019 | 1.05x | CN¥263.23 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -3.4% |
| 2018 | 1.08x | CN¥354.39 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥567.68 Million | CN¥369.91 Million | CN¥124.28 Million | ▼ -38.1% |
| 2016 | 2.48x | CN¥838.45 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -12.1% |
| 2015 | 2.82x | CN¥542.27 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +42.2% |
| 2014 | 1.98x | CN¥199.54 Million | CN¥100.60 Million | CN¥199.54 Million | ▲ +96.7% |
| 2013 | 1.01x | CN¥111.91 Million | CN¥110.95 Million | CN¥111.91 Million | ▲ +85.5% |
| 2012 | 0.54x | CN¥77.42 Million | CN¥142.38 Million | CN¥77.42 Million | ▼ -79.3% |
| 2011 | 2.63x | CN¥185.41 Million | CN¥70.56 Million | CN¥185.41 Million | ▲ +259.6% |
| 2010 | 0.73x | CN¥67.02 Million | CN¥91.72 Million | CN¥67.02 Million | ▲ +222.9% |
| 2009 | 0.23x | CN¥22.83 Million | CN¥100.89 Million | CN¥22.83 Million | ▼ -15.4% |
| 2008 | 0.27x | CN¥19.49 Million | CN¥72.86 Million | CN¥19.49 Million | ▼ -48.6% |
| 2007 | 0.52x | CN¥25.67 Million | CN¥49.35 Million | CN¥25.67 Million | ▼ -5.4% |
| 2006 | 0.55x | CN¥9.84 Million | CN¥17.91 Million | CN¥9.84 Million | — |